Lilly is acquiring all commercial and intellectual property rights to Organovo’s FXR program for worldwide development and will be responsible for all future clinical development.

SAN DIEGO - Organovo Holdings, Inc. (NASDAQ:ONVO), a biotech firm specializing in inflammatory bowel disease treatments, announced the sale of its FXR Program to pharmaceutical giant Lilly (NYSE ...

SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo” or the "Company”), a clinical stage biotechnology company focused on developing novel treatment ...

Fans looking to hit some home runs on the go can do just that when Backyard Baseball '97 comes to Android and iOS mobile devices on Mar. 27. This marks the iconic Backyard Sports franchise's first ...

The carpet bombing of Voronezh is not far away. The Russian Ministry of Defense itself presented evidence that it was Russian occupiers who attacked the Sudzha gas measuring station near the border ...

Hong Kong property magnate Lee Shau Kee, one of the city’s richest men, died on Monday at the age of 97, Henderson Land, the group that he founded, said in a statement. Nicknamed “Uncle Four ...

The Estimates data displayed by Moneycontrol is not a recommendation to buy or sell any securities. Estimates data is a third party aggregated data provided by S&P Global Market Intelligence LLC ...

Obesity is a growing global epidemic and a major risk factor for cardiovascular disease. However, previous weight loss interventions have largely failed to demonstrate consistent cardiovascular ...

Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein ...

Albert Erlon Mosher has lived and worked on his ancestors' Long View Farm he took over from his father in 1967, carrying on a tradition that began in 1738. Gorham’s Albert Erlon Mosher, turning ...